Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.mehy.2020.109765 http://scihub22266oqcxt.onion/10.1016/j.mehy.2020.109765 32361588!7195103!32361588     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Med+Hypotheses 2020 ; 140 (ä): 109765 Nephropedia Template TP {{tp|p=32361588|t=2020. Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19 |pdf=|usr=}}{{32361588}} gab.com Text Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19 JO: Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=32361588 #FOAvip Corona virus disease 2019 (COVID-19) pandemic caused 18 440 deaths world wide as of 25 March 2020 and posing a serious threat to public health. There is a need, therefore, for effective therapeutic strategies to cure this disease. However, high attrition rates, substantial costs and slow pace are the major limitations of novel drug discovery. Drug repurposing, by employing 'old' drugs to treat 'new' diseases is an attractive approach in drug discovery. Niclosamide (NIC) is an approved anti-helminthic drug with diverse antiviral mechanisms. In this work we hypothesize, the potential antiviral mechanisms of NIC against COVID-19. Twit Text FOAVip Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19 ????Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=32361588 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32361588 #FOAvip English Wikipedia <ref>{{Cite pmid|32361588}}</ref> Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19 #MMPMID32361588 Pindiprolu SKSS; Pindiprolu SH Med Hypotheses 2020[Apr]; 140 (ä): 109765 PMID32361588show ga Corona virus disease 2019 (COVID-19) pandemic caused 18 440 deaths world wide as of 25 March 2020 and posing a serious threat to public health. There is a need, therefore, for effective therapeutic strategies to cure this disease. However, high attrition rates, substantial costs and slow pace are the major limitations of novel drug discovery. Drug repurposing, by employing 'old' drugs to treat 'new' diseases is an attractive approach in drug discovery. Niclosamide (NIC) is an approved anti-helminthic drug with diverse antiviral mechanisms. In this work we hypothesize, the potential antiviral mechanisms of NIC against COVID-19. äPlausible mechanisms of Niclosamide as an antiviral agent against COVI(epmc).pdf DeepDyve Pubget Overpricing